Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > April 2004

« Previous month Next month »

Oligo suppliers should look to their laurels

29-Apr-2004 - Manufacturers of custom synthetic oligonucleotides (oligos) could see competition from new entrants into the sector, according to a survey which finds that customers are not entirely happy with their suppliers.

Recordati sells Sophartex, expands Polfa Kutno stake

29-Apr-2004 - Italy's Recordati has sold off Sophartex, a French subsidiary specialising in the contract manufacture of finished pharmaceutical dosage forms, continuing its strategy of divesting businesses outside its core focus of...

Catalysts from UK start-up promise cleaner, greener reactions

29-Apr-2004 - A new company spun out from the University of Durham in the UK, called LyraChem, has developed a new catalytic technology for the pharmaceutical and chemical sectors that should reduce...

Comark products to get cross-contamination protection

29-Apr-2004 - A UK-based specialist in antimicrobial coating technology, BioCote, has entered into an agreement with Comark to develop more hygienic handheld thermometers and data loggers. The new products are intended for...

DSM outperforms expectations in 1Q

28-Apr-2004 - DSM has said it expects 'clearly higher' net profit from ordinary operations in 2004, after reporting an unexpected increase in first-quarter operating earnings.

French study evaluates consequences of REACH legislation

28-Apr-2004 - The impact on the French chemicals industry of implementing the European Union's REACH (Registration, Evaluation and Authorisation of Chemicals) proposals could be as high €800 million in testing alone and...

US approval for Profile's nebuliser

28-Apr-2004 - Profile Therapeutics of the UK has been granted approval from the US Food and Drug Administration (FDA) for Prodose, its nebuliser system that can improve the delivery of inhaled drugs.

DMV ramps up excipient capacity with new plant

28-Apr-2004 - DMV International, the industrial ingredients division of the Netherlands' Campina, is planning to open a dedicated facility in Germany for the production of excipients for direct compression.

New granulator from L B Bohle

28-Apr-2004 - Germany's L B Bohle, a specialist in dispensing, granulating and milling equipment, has introduced a new granulator for pharmaceutical applications that allows for continuous throughput of materials.

Management buy-out at Lurgi Life Science

28-Apr-2004 - Lurgi, part of the mg technology group, has sold off a pharmaceutical and chemical engineering unit to two former executives in a management buyout.

Lonza teams up with RNA-TEC for oligo production

27-Apr-2004 - Switzerland's Lonza, one of the leading contract manufacturers of active pharmaceutical ingredients, has forged a collaboration with RNA-TEC of Belgium to provide broad-ranging contract production of oligonucleotides, a new class...

Captisol hikes budesonide delivery to lungs

27-Apr-2004 - A formulation of the steroid drug budesonide, made using a solubility technology developed by US company CyDex, has outperformed one of the leading drugs for asthma on the market in...

EC mulls progress in European biotech

27-Apr-2004 - The European Commission has reported on its progress in building up Europe's competitiveness in the biotechnology and concludes that while positive steps have been taken, there is still much to...

Seconds out in fast-melt lawsuit

27-Apr-2004 - St Louis, USA-based KV Pharmaceutical says that the US District Court for the District of Minnesota has denied a motion for a preliminary injunction by two rival drug delivery companies...

Sanofi-Aventis looks likely as Novartis ducks out

26-Apr-2004 - Switzerland's Novartis has decided to withdraw from any negotiations with Aventis over a possible merger, after official discussions with the latter and fellow French-based company Sanofi-Synthelabo got underway.

Rhodia makes €400m from divestments

26-Apr-2004 - French chemicals company Rhodia has announced three new deals which keep it on track to divest €700 million-worth of businesses by the end of the year as it aims for...

Research reveals scale of child-proof packaging problems

26-Apr-2004 - Designers of child-proof packaging must always work against the paradox that a package which is hard for a child to open can often also be difficult for the adult patient...

Safety syringe goes into production

26-Apr-2004 - US company Globe Medical Tech has started production of a new type of safety syringe developed by Maxxon that should cost no more than a regular, non-safe disposable syringe.

Swedish intelligent packaging trials underway

26-Apr-2004 - Swedish company Cypak has started two trials of its Intelligent Pharmaceutical Packaging (IPP) technology, which offers an alternative to radiofrequency identification (RFID) for tracking the use of medicines.

Ulster says yes to nanotechnology

22-Apr-2004 - The University of Ulster yesterday opened a new Nanotechnology Research Institute at its Jordanstown campus in Northern Ireland, and says it is the only institute of its type in the...

Stedim enlists US partner to offer streamlined biomanufacturing

22-Apr-2004 - Developer of disposable container systems Stedim has teamed up with a Californian firm to bring to market an alternative to conventional media kitchens, designed to reduce the costs of biomanufacturing.

New player on biomanufacturing scene

22-Apr-2004 - The US-based Cook Group is to enter the biomanufacturing sector, revealing an initial $45 million investment in a state-of-the-art facility.

Strong sales for Millipore, good sign for biopharma

22-Apr-2004 - Filtration specialist Millipore has reported impressive growth in sales in the first quarter of 2004, suggesting that the strength of the biopharmaceutical industry - Millipore's primary customer - may be...

Novartis introduces film strips for flu range

22-Apr-2004 - Novartis Consumer Health has launched two of its OTC flu remedies in portable dissolvable strips, thought to be the first such products to use the novel delivery format.

Elan finds new partner for NanoCrystal tech

21-Apr-2004 - Ireland's Elan Corp has signed up another heavyweight partner - Switzerland's Roche - for its NanoCrystals technology, designed to improve the solubility of drug compounds.

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Events from partners...